Safety of Paclitaxel in a Patient with Ovarian Cancer and Hyperbilirubinemia Due to Rotor's Syndrome

Author： Argon A.   Aydiner A.   Tas F.   Saip P.   Topuz E.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.2, 2002-05, pp. : 362-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Paclitaxel and Cisplatin in a Patient with Epithelial Ovarian Cancer and Human Immunodeficiency Virus

By Knox S.N.   Robinson J.B.   Im D.D.   Logan L.   Rosenshein N.B.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 118-122

Elsevier

Access to resources Recommend Favorite

Paclitaxel and Carboplatin Combination Chemotherapy in a Hemodialysis Patient with Advanced Ovarian Cancer

By Watanabe M.   Aoki Y.   Tomita M.   Sato T.   Takaki Y.   Kato N.   Kikuchi M.   Kase H.   Tanaka K.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 335-338

Elsevier

Access to resources Recommend Favorite

Management of a patient with colon cancer and rotor syndrome: A case report

By          

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 797-798

Spandidos Publications

Access to resources Recommend Favorite

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

By Choi Chel   Kim Min   Park Jin-Young   Yoon Aera   Kim Ha-Jeong   Lee Yoo-Young   Kim Tae-Joong   Lee Jeong-Won   Kim Byoung-Gie   Bae Duk-Soo  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1181-1187

Springer Publishing Company

Access to resources Recommend Favorite

A case of chronic paclitaxel administration in ovarian cancer

By von Gruenigen V.E.   Karlen J.R.   Waggoner S.E.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 532-535

Elsevier

Access to resources Recommend Favorite